An official website of the State of Oregon Learn How you know » (how to identify a Oregon.gov website) An official website of the State of Oregon »
You are here:
The Oregon Prescription Drug Price Transparency program provides the board with prescription drug data submitted under ORS 646A.689 (2) and (6), and ORS 743.025. Information about insulin comes from the Oregon Health Authority’s All Payer All Claims (APAC) reporting program. Information is aggregated and de-identified. The board strictly maintains the confidentiality of any information collected, used or relied upon for the review that is protected trade secret, confidential, or proprietary information, as defined in ORS 192.345.
Jan. 10, 2024 affordability review reports
Prescription drug and insulin list for affordability review (approved by the board on Dec. 13, 2023)
Dec. 13, 2023 board revised subset lists
On October 18, 2023, the board selected a subset list of prescription drugs pursuant to OAR 925-200-0010
Data for board review on September 20, 2023
A .gov website belongs to an official government organization in the United States.
A lock icon ( ) or https:// means you’ve safely connected to the .gov website.
Your browser is out-of-date! It has known security flaws and may not display all features of this and other websites. Learn how
×